07-3762-cr
USA v. Akpan
UNITED STATES COURT OF APPEALS
FOR THE SECOND CIRCUIT
SUMMARY ORDER
RULINGS BY SUM M ARY O RDER DO NOT HAVE PRECEDENTIAL EFFECT. CITATION TO A
SUM M ARY ORDER FILED ON OR AFTER JANUARY 1, 2007, IS PERM ITTED AND IS GOVERNED BY
FEDERAL RULE OF APPELLATE PROCEDURE 32.1 AND THIS COURT’S LOCAL RULE 32.1.1. W HEN
CITING A SUM M ARY ORDER IN A DOCUM ENT FILED W ITH THIS COURT, A PARTY M UST CITE
EITHER THE FEDERAL APPENDIX OR AN ELECTRONIC DATABASE (W ITH THE NOTATION
“SUM M ARY ORDER”). A PARTY CITING A SUM M ARY ORDER M UST SERVE A COPY OF IT ON ANY
PARTY NOT REPRESENTED BY COUNSEL.
At a stated term of the United States Court of Appeals for the Second Circuit, held at
the Daniel Patrick Moynihan United States Courthouse, 500 Pearl Street, in the City of New
York, on the 21 st day of January, two thousand ten.
PRESENT: DENNIS JACOBS,
Chief Judge,
ROSEMARY S. POOLER,
REENA RAGGI,
Circuit Judges.
------------------------------------------------------------------
UNITED STATES OF AMERICA,
Appellee,
v. No. 07-3762-cr
GODWIN J. AKPAN,
Defendant-Appellant.
--------------------------------------------------------------------
SUBMITTING FOR APPELLANT: MAURICE H. SERCARZ, Sercarz & Riopelle,
LLP, New York, New York.
SUBMITTING FOR APPELLEE: RITA M. GLAVIN, Assistant United States
Attorney (Jonathan S. Kolodner, Assistant United
States Attorney, on the brief) for Michael J.
Garcia, United States Attorney for the Southern
District of New York, New York, New York.
1
Appeal from the United States District Court for the Southern District of New York
(Kimba M. Wood, Chief Judge).
UPON DUE CONSIDERATION, IT IS HEREBY ORDERED, ADJUDGED, AND
DECREED that the judgment of conviction, entered on August 28, 2007, is AFFIRMED.
Defendant Godwin J. Akpan, who was convicted of committing health-care fraud and
submitting false statements in connection therewith, see 18 U.S.C. §§ 1347, 1035, appeals
from that portion of the judgment sentencing him to a 37-month term of imprisonment.
In the aftermath of United States v. Booker, we review sentences for
“reasonableness,” 543 U.S. 220, 262 (2005), “a deferential standard limited to identifying
abuse of discretion regardless of whether a challenged sentence is ‘inside, just outside, or
significantly outside the Guidelines range,’” United States v. Jones, 531 F.3d 163, 170 (2d
Cir. 2008) (quoting Gall v. United States, 552 U.S. 38, 40 (2007)). Our review proceeds in
two steps: first, we must “ascertain whether the sentence was administered without
procedural error,” United States v. Williams, 524 F.3d 209, 214 (2d Cir. 2008); and second,
if the sentence is “procedurally sound,” we must “consider [its] substantive reasonableness,”
Gall v. United States, 552 U.S. at 51, by evaluating “whether the District Judge abused his
discretion in determining that the [18 U.S.C.] § 3553(a) factors supported” the sentence
imposed, id. at 56. In applying reasonableness review to this case, we assume the parties’
familiarity with the facts and the record of prior proceedings, which we reference only as
necessary to explain our decision.
2
Akpan submits that the district court committed procedural error in employing a 12-
level enhancement when calculating the offense level relevant to his Sentencing Guidelines
range because the evidence did not support an intended loss exceeding $200,000. See U.S.
Sentencing Guidelines Manual § 2B1.1(b)(1) (2005). We review the challenged factual
finding for clear error, see United States v. Kerley, 544 F.3d 172, 179 (2d Cir. 2008), and
identify none in this case.
Akpan does not contest that the government proved at trial that, through his company,
Goodlife Medical Supplies (“GMS”), he caused an intended loss of $107,000 by submitting
numerous false claims for reimbursement to Medicare. Indeed, the jury convicted Akpan of
submitting $43,000 worth of charged false claims, and the district court specifically credited
those witnesses who testified that he submitted a further $64,000 worth of uncharged ones.
Instead, Akpan argues that the financial records and forged certificates of medical necessity
(“CMNs”) seized from GMS did not support the district court’s finding that $200,000 was
a “reasonable estimate” of the total intended loss. U.S. Sentencing Guidelines Manual
§ 2B1.1 cmt. n.3(C). We disagree.
The $107,000 loss was reflected in only 28 specific false claims. The district court
found that GMS’s financial records showed that the company submitted 149 claims of
reimbursement for motorized wheelchairs when, in fact, its own records established that
GMS purchased only 12. Based on that fact, the district court did not clearly err when,
rejecting Akpan’s unsubstantiated assertion that he purchased additional wheelchairs and
3
scooters from various distributors, it concluded that GMS acquired less than one-third of the
wheelchairs and accessories Akpan claimed to have delivered to beneficiaries. Given
Akpan’s proven practice of submitting false claims for items never given to beneficiaries,
it was also more than reasonable for the district court to infer that the financial records
evidenced a similar fraudulent practice, rather than, as Akpan submits, a coding, billing, or
some other innocent error. See United States v. Uddin, 551 F.3d 176, 180-81 (2d Cir. 2009)
(upholding loss estimate where “‘known’ data” regarding predicate transactions’ comparative
nature and context suggested that they were fraudulent); see also United States v.
MacPherson, 424 F.3d 183, 191 (2d Cir. 2005) (holding that pattern evidence could support
inference of intent). Finally, by finding that the price of each wheelchair was $5,100 (which
Medicare reimbursed at a rate of 80%), the district court appropriately deduced that the
intended loss “easily exceed[ed]” $200,000. Sentencing Tr. at 20.
Independent of GMS’s financial records, the district court’s loss finding was also
supported by inferences drawn from the forged CMNs. Specifically, the district court found
that (1) there existed 21 forged CMNs that were not included as part of the $107,000 figure
proved at trial, (2) Akpan intended to use these CMNs to submit false reimbursement claims
for $90,000 worth of motorized wheelchairs, and (3) Akpan intended to use other forged
CMNs (that is, CMNs for items other than wheelchairs) to defraud Medicare of a further
$4,000. Combining these figures with the $107,000 proved at trial, the district court
appropriately concluded that the sum total of the intended loss was over $200,000. Akpan’s
4
suggestion that the district court improperly double-counted these CMNs to reach the
$200,000 figure is factually incorrect. The district court relied on CMNs that were not
included in the $107,000 proved at trial, and, because the CMNs provided an alternative and
independent route to calculate the $200,000 intended-loss figure, it is irrelevant that some
or even all of these CMNs could have been used in connection with the 149 claims
documented in GMS’s financial records.
We acknowledge, as does the government, that the district court apparently misspoke
when it initially characterized the $107,000 loss proved at trial as an amount “additional” to
— rather than inclusive of — the $43,000 attributable to the charged claims. Sentencing Tr.
17. But given Akpan’s admission that the government proved a loss of $107,000 at trial, and
the district court’s record-based finding of a $200,000-plus intended loss, it is clear that any
misstatement was a harmless “slip of the tongue” not warranting remand. United States v.
Grimes, 225 F.3d 254, 260 (2d Cir. 2000); see also United States v. Sanchez, 517 F.3d 651,
665 (2d Cir. 2008) (explaining that remand to clarify record ambiguity is unnecessary if it
is clear that district court would have imposed same sentence in any event).
The judgment is AFFIRMED.
For the Court:
CATHERINE O’HAGAN WOLFE, Clerk of Court
5